IPO
Hong Kong vs Singapore: New economy IPOs
Hong Kong and Singapore are both keen to attract listings by high-growth technology companies. Some of the targets are the same, but the strategic positioning is different
China's Giant Biogene trades up after $70m Hong Kong IPO
Giant Biogene, a China-based producer of skin treatments that use bioactive ingredients, gained nearly 10% on debut following a HKD 549.4m (USD 70m) Hong Kong IPO.
Investors endorse 'long Chinese' thesis - AVCJ webinar
The shift from “long China” to “long Chinese,” which has gained traction as a soundbite as investors look to back local entrepreneurs in overseas markets, was highlighted once again during AVCJ’s China Private Markets Outlook webinar.
Warburg Pincus, Malabar commit $60m to India wearables brand
Warburg Pincus and Malabar Investments have injected USD 60m into boAT, an India-based manufacturer of wearables and other electronic devices that was previously on track for an IPO.
China's Welkin Capital puts IPO on hold
China’s Welkin Capital has paused a planned USD 300m London IPO for an entity seeded with assets from its debut private equity fund, citing macro uncertainty and market volatility.
Profile: Charles Li
Charles Li became known as a financial markets reformist during his stint in charge of Hong Kong’s stock exchange. He continues in the same vein at the helm of fintech start-up Micro Connect
VC-backed Singapore biotech start-up agrees SPAC merger
Singapore’s AUM Biosciences, a VC-backed oncology treatments developer, has agreed to a NASDAQ listing via special purpose acquisition company (SPAC) at a pre-money equity valuation of USD 400m.
AVCJ Awards 2022 - voting has closed
Voting for the 2022 AVCJ Private Equity & Venture Capital Awards has now closed. Many thanks for your participation.
Deal focus: Food app targets Thailand's first internet IPO
Thai restaurant delivery app Line Man Wongnai has leveraged the massive messaging service penetration of its parent company to position itself for what is hoped to be a breakthrough IPO
3Q analysis: Lean times
A flicker in India fails to disguise a miserable quarter for exits; a handful of fast fundraises snap Asia out of its slump; investment gravitates towards developed markets and manufacturing
Investors call on Japanese start-ups to pursue overseas capital - AVCJ Forum
Japanese start-ups must attract more institutional capital from overseas given the paucity of local investors, especially in the growth stages, the AVCJ Japan Forum heard.
Currency, exit, labour issues worry Japanese GPs - AVCJ Forum
Currency depreciation, dwindling domestic IPO opportunities, and labour shortages are all their toll on the portfolios of middle-market Japanese private equity firms, the AVCJ Japan Forum heard.
VC-backed Asia streaming business agrees SPAC merger
Asia Innovations Group (ASIG), a social media, gaming, and e-commerce business best known for the Uplive streaming platform, has agreed to merge with a US-listed special purpose acquisition company (SPAC) at an equity valuation of USD 2.5bn.
PE-backed Mankind Pharma files for India IPO
Indian drug maker Mankind Pharma has filed for a domestic IPO, setting up an exit for Capital International, a private equity arm of Capital Group.
TPG-backed Dingdang Health raises $51m in Hong Kong IPO
Chinese online pharmacy platform Dingdang Health has raised HKD 402.4m (USD 51m) through a Hong Kong IPO, defying challenging conditions for financial sponsors targeting the bourse.
China AI player Fourth Paradigm files for Hong Kong IPO
Fourth Paradigm, a China-based software provider that helps enterprise customers develop in-house artificial intelligence (AI) decision-making applications, has filed for a Hong Kong IPO.
Shenzhen investors offered cash handouts for Hong Kong IPOs
Shenzhen-based venture capital investors will receive one-off cash rewards for taking companies public in Hong Kong and sponsoring special purpose acquisition companies (SPACs) that list on the territory’s stock exchange.
China fitness app Keep pursues Hong Kong listing
Keep, a China-focused fitness app operator backed by the likes of GGV Capital, SoftBank Vision Fund 2, and 5Y Capital, has filed for a Hong Kong IPO.
China's Welkin Capital targets London IPO
China-focused Welkin Capital is looking to raise up to USD 300m through an IPO for a London-listed investment entity seeded with assets from its debut private equity fund, which closed in 2017.
China EV player Leapmotor targets Hong Kong IPO
LeapMotor has filed for an IPO in Hong Kong, putting it on course to become the fourth of China's "new force" electric vehicle (EV) manufacturers to go public.
PE-backed Korean ride-sharing player Socar drops on debut
Socar, a Korea-based car-sharing business backed by the likes of Bain Capital, IMM Private Equity, and SoftBank Ventures Asia, traded down on debut following a KRW 101.9bn (USD 76m) IPO.
AVCJ Awards 2022 - nominations have closed
Nominations for the 2022 AVCJ Private Equity & Venture Capital Awards have now closed. Many thanks to all those who participated.
Quadria plans full exit through Concord Biotech's India IPO
Singapore-based healthcare specialist Quadria Capital is set for a full exit from pharmaceuticals industry supplier Concord Biotech via an India IPO.
SE Asia exits set for near-term turbulence, long-term strength - AVCJ Forum
Private equity exits will remain challenging this year as buyers and sellers drift further apart on pricing, investors told the AVCJ Southeast Asia Forum, although their long-term outlook for liquidity in the region remains reasonably bullish.